COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead More About CSL Behring's Efforts with COVID-19
Infographic: All That Plasma Can Do
From immune system problems to bleeding disorders and more – plasma-based therapies treat many health conditions.
At home in Germany, Alpha 1 Athlete Karen Skålvoll misses travel and competitions. These days, you can find her in the garden…
Listen: Adapting to Change
Podcast features bleeding disorder experts in celebration of World Hemophilia Day.
Helping Golfers Get a Grip
Pro golfer and bleeding disorders advocate Perry Parker offers tips – and encouragement – for improving your game
Boosting Young Scientists
CSL Behring in Bern, Switzerland, awards scholarships to three top students.
NFL Players Cheer On Rare Disease Research
Uplifting Athletes presents $140,000 in research grants in the Young Investigator Draft.
Calling All Innovators
Your inventive idea could help the growing number of patients who rely on plasma-derived immunoglobulin.